To provide competitive long term growth through direct and indirect investment principally in a broad portfolio of securities issued by UK companies.
Name | % Net Assets |
---|---|
AstraZeneca | 7.5% |
BG Group | 7.5% |
BP | 7.0% |
Xstrata | 6.5% |
HSBC Holdings | 5.9% |
KSK Power Ventur | 5.5% |
Great Eastern Energy | 4.7% |
BHP Billiton | 4.6% |
Berkeley Group | 3.6% |
Hardy Oil & Gas | 3.5% |
Key | % Net Assets |
---|---|
AstraZeneca | 7.5% |
BG Group | 7.5% |
BP | 7.0% |
Xstrata | 6.5% |
Other | 71.5% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 16/11/1958 |
---|---|
Fund Manager | Peter Cockburn |
TER | 1.63 (31-Jan-2011) |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.12 |
You are here: research